Invadopodium formation is a crucial early event of invasion and metastasis of hepatocellular carcinoma (HCC). However, the molecular mechanisms underlying regulation of invadopodia remain elusive. This study aimed to investigate the potential role of discs large homolog 5 (Dlg5) in invadopodium formation and function in HCC. We found that Dlg5 expression was significantly lower in human HCC tissues and cell lines than adjacent nontumor tissues and liver cells. Lower Dlg5 expression was associated with advanced stages of HCC, and poor overall and disease-free survival of HCC patients. Dlg5-silencing promoted epithelial-mesenchymal transition, invadopodium formation, gelatin degradation function, and invadopodium-associated invasion of HepG2 cells. In contrast, Dlg5 overexpression inhibited epithelial-mesenchymal transition, functional invadopodium formation, and invasion of SK-Hep1 cells. Both Girdin and Tks5, but not the Tks5 nonphosphorylatable mutant, were responsible for the enhanced invadopodium formation and invasion of Dlg5-silenced HepG2 cells. Furthermore, Dlg5 interacted with Girdin and interfered with the interaction of Girdin and Tks5. Dlg5 silencing promoted Girdin and Tks5 phosphorylation, which was abrogated by Girdin silencing and rescued by inducing shRNA-resistant Girdin expression. Moreover, Dlg5 overexpression significantly inhibited HCC intrahepatic and lung metastasis in vivo. Taken together, our data indicate that Dlg5 acts as a novel regulator of invadopodium-associated invasion via Girdin and by interfering with the interaction between Girdin and Tks5, which might be important for Tks5 phosphorylation in HCC cells. Conceivably, Dlg5 may act as a new biomarker for prognosis of HCC patients.
Patients with metastatic hepatocellular carcinoma (HCC) usually have a poor prognosis. 1 However, the molecular mechanisms underlying HCC invasion and metastasis remain elusive. Invadopodia are unique actin-rich protrusions of the plasma membrane in invasive cancer cells and associated with adhesion to and degradation of extracellular matrix during the process of cancer invasion and metastasis. 2, 3 Previous studies have suggested that invadopodia may participate in penetration surrounding tissues, intravasation into and extravasation from circulation, migration, and localization of cancer cells in distant sites. 3, 4 Hence, invadopodia may be valuable targets for anticancer metastasis. 3 Tyrosine kinase substrate with five SH3 domains (Tks5, five SH3 domains, FISH, or SH3 multiple domains 1), a substrate of Src, is the master scaffold for invadopodium formation and function. 5, 6 Src-dependent phosphorylation of human Tks5 at Y530/Y592 (corresponding to mouse Tks5 Y557/Y619) is important for recruiting adaptor proteins to assemble an F-actin network in Tks5-rich invadopodium precursors, and for invadopodium-associated matrix degradation in melanoma and prostate cancer cells. [7] [8] [9] However, the precise mechanisms underlying aberrant Tks5 activation, invadopodium formation, and function have not been fully understood and remain a virgin territory in HCC. 10 Discs large homolog 5 (Dlg5) is a member of the membrane-associated guanylate kinase family. 11 Dlg5 is required for the maintenance of adherens junctions and epithelial cell polarity in mammalian brain, kidneys, 12 and lungs. 13 Recent studies suggest that Dlg5 may inhibit epithelial-mesenchymal transition (EMT) in renal epithelial cells and prostate cancer cells by attenuating TGF-b1 signaling. 14, 15 Indeed, downregulated Dlg5 expression is detected in aggressive malignancies. [16] [17] [18] [19] However, little is known about how Dlg5 regulates cancer cell invasion and metastasis. Notably, Dlg5 can interact with girders of actin filament (Girdin) and inhibit Akt-mediated phosphorylation of Girdin at Ser-1416 in prostate cancer PC3 cells. 18 Girdin is a crucial regulator of invasion and metastasis of cancer cells. 20, 21 Recently Leyme et al. 22 found that Girdin localized in focal adhesion (a notion that invadopodia are initiated at focal adhesion 5 ) of MDA-MB-231 cells and in invadopodia of NIH3T3-Src-Y527F cells though they did not determine its potential role in invadopodia. Our preliminary studies observed that Girdin interacted with SH3 multiple domains 2, a protein with Tks5 in the same family (Wang L, unpublished data). Moreover, Girdin is necessary for FAK Tyr397 and Src Tyr418 phosphorylation, both are involved in Tks5 activation and invadopodium development. 22 ,23 Accordingly, we hypothesize that Dlg5 may regulate the formation and function of invadopodia and invasion of HCC cells by interacting with Girdin to inhibit its binding to Tks5 and Tks5 phosphorylation by Girdin-dependent FAK/Src activity.
In this study, we tested the hypothesis using HCC specimens, HCC cell lines, and xenografts in nude mice as in vitro and in vivo models. The results indicated that Dlg5 inhibited HCC invasion at least partly by inhibiting invadopodia-mediated matrix degradation via a mechanism that required Girdin and Tks5.
Material and Methods

Human cell lines and samples
Human hepatoma HepG2, SMMC-7721, and SK-Hep1 cells were from the Kunming Institute of Zoology, Chinese Academy of Sciences (Kunming, China). MHCC97-L, nontumor HL-7702 liver cells, and HEK-293FT cells were from Xiangf Bio (Shanghai, China). The cells were cultured in RMPI1640 containing 10% fetal bovine serum (Life Technologies, USA).
A total of 108 HCC patients, who underwent hepatectomy, were recruited at the Department of Hepatobiliary Surgery, the Second Affiliated Hospital of Kunming Medical University from January 2008 to December 2009. Those patients with HCC were diagnosed, according to the AASLD practices guidelines on the management of HCC (2005 version). 24 Individuals with a history of previous chemotherapy or radiotherapy (n 5 0) and incomplete medical records (n 5 8) were excluded. Tumor specimens and corresponding adjacent liver tissues (2 cm from the tumors) from the remaining 100 patients were used for immunohistochemistry. Patients were followed up until December 2015. Their survival was analyzed, and demographic and clinical data are shown in Supporting Information, for 15 min, and blocked with 5% goat serum from healthy animals in PBS-T. After being washed, the sections were incubated with primary anti-Dlg5 antibodies (1: 200) overnight at 48C, and the bound antibodies were detected with HRP-anti-rabbit IgG (Dako, Carpinteria, USA) at room temperature for 30 min followed by staining with diaminobenzidine and counterstaining with hematoxylin. The sections without primary antibodies served as negative controls. The levels of Dlg5 expression were semi-quantitatively analyzed using a scoring system in a blind manner. The percentages of positively stained HCC cells (or liver cells in the adjacent specimens) were scored as follows: 0 (0%), 1 (1-10%), 2 (11-50%), and 3 (>50%). The signal intensity was visually analyzed as follows: 0 (negative), 1 (weak), 2 (moderate), and 3 (strong). A final score for each specimen was calculated by multiplying the percentage and signal intensity scores. A specimen with a final score 4 (median of the final scores of Dlg5) was considered to be a high level of Dlg5 expressions, and other scores were considered to be a low expression.
Cell line modification
Oligonucleotides for small hairpin RNAs (shRNAs) targeting the Dlg5 were synthesized from Obio (Shanghai, China) and their sense sequences were 5
, and a control shRNA sequence of 5 0 -TTCTCCGAACGTGTCACGT-3 0 . These pairs of oligonucleotides were annealed and cloned into pLKD-CMV-PuroR-U6-shRNA expression vector. The generated plasmids, together with packaging plasmids, were cotransfected into 293FT cells using lipofectamine 3000 (Invitrogen, Carlsbad, USA), respectively, to generate different types of recombinant lentivirus virions. HCC cells were infected with shRNA-expressing recombinant lentivirus and treated with 1 lg/ml puromycin to generate Dlg5-stably silencing cells. Tks5 or Girdin silencing in the control or Dlg5-silenced HCC cells was generated using the pLKO.1-Neo lentiviral vector by incorporating human Tks5-or Girdin-targeting shRNAs validated previously, 8, 23 respectively (Tks5 shRNA1:
0 ; Fitgene, Guangzhou, China). Control HCC cells were infected with pLKO.1-Neo expressing a scrambled shRNA. Following infection, the cells were treated with 500 lg/ml G418 to obtain stably silencing of target gene.
The adenoviruses bearing shRNA-resistant Dlg5, Girdin, Tks5 cDNAs, or Tks5 nonphosphorylatable mutants (Tks5-Y530F/Y592F) 8, 9 were prepared using a shuttle vector pDC316 and the Admax system (Microbix Biosystems, Toronto, Canada). HepG2 Dlg5, Girdin, or Tks5-silencing cells were infected for 48 hr with corresponding recombinant adenoviruses using Envirus TM -AdV (Engreen Biosystem, Beijing, China), respectively. Point mutations were generated using a QuickChange lightening site-directed mutagenesis kit (Agilent Technology, Santa Clara, CA, USA) and validated by sequencing. To establish Dlg5-stably overexpressing cells, SK-Hep1 cells were transfected with control pcDNA3.1(1) or Dlg5-expressing H302 pcDNA3.1(1) (Obio) using lipofectamine 3000 and the positively transduced cells were selected by treatment with neomycin. The levels of targeted gene expression in different types of cells were determined by Western blot.
Western blot
The relative levels of target protein expression were determined by Western blot using the cell lysates or immunoprecipitated proteins (30 lg/lane) and specific antibodies described in Supporting Information. 25 Because there was no commercial antibody available for detecting phosphortyrosine sites of Tks5, Tks5 was first immunoprecipitated from total cell lysates, and then immunoblotted with antiphosphotyrosine antibody to detect its tyrosine phosphorylation (Tks5-pY530/pY592). [7] [8] [9] Because anti-phosphor-Src and FAK antibodies may cross-react with other Src family kinases (such as Yes, Fyn, and Fgr) and receptor tyrosine kinases, respectively, which phosphorylated at the equivalent sites, 2 the total Src and FAK were immunoprecipitated and probed with antiphosphor antibodies to accurately identify the levels of Src and FAK phosphorylation. This approach was also used for detecting phosphor-Girdin to ensure specificity.
Immunoprecipitation
The interaction among Dlg5, Girdin, and Tks5 in HCC cells was determined by immunoprecipitation 18 using anti-Dlg5, anti-Girdin, anti-Tks5, or control IgG and protein G agarose beads (ThermoFisher Scientific). The protein bound to the beads were eluted and analyzed by Western blotting using the indicated antibodies listed in Supporting Information.
Immunofluorescent assays
Invadopodium formation in HCC cells was determined by immunofluorescent assays 2 using rabbit anti-Tks5 (1:200; Millipore)/anti-Cortactin (1:200; Millipore), FITC-conjugated goat anti-rabbit IgG (1:1000; Santa Cruz Biotechnology), and Alexa Fluor 568-conjugated phalloidin (for F-actin staining, 1:200; Molecular Probes). Co-localization of F-actin with the unique adaptor protein Tks5 or the nucleation-promoting factor Cortactin (specified where used including in the context of Tks5 knockdown) was used to determine invadopodium formation. 2 For monitoring the gelatin degradation by invadopodia (viz., invadopodium function), 2 HCC cells were cultured for 4-8 hr on coverslips that have been uniformly loaded with a mixture of FITC-gelatin (ThermoFisher Scientific) and 0.5% unlabeled gelatin at a ratio of 1:8, and stained with Alexa Fluor 568-conjugated phalloidin and DAPI. Invadopodiumassociated gelatin degradation was defined as F-actin puncta co-localizing with gelatin degradation. 2 To quantify the gelatin degradation activity of invadopodia, the degradation areas in images were analyzed using the FIJI software and normalized to the total number of cells in each image. The values of control cells were designated as 1, and the relative values of other groups of cells were calculated accordingly. Some other parameters were used: percentages of cells with invadopodia, the numbers of invadopodia per cell, and percentages of cells with gelatin degradation. 2 Data were calculated from three independent experiments of at least 150 cells in 10 random images with a 603 object per experiment.
To evaluate the accurate extent of co-localization between Girdin and Tks5 before and after Dlg5 silencing, regions of interest were drawn around the cytoplasm of 10-15 cells per experiment and the Pearson's correlation coefficient of relative fluorescent intensities of Girdin and Tks5 was determined using the Coloc2 plugin of FIJI. 23 
Orthotopic liver xenograft model
, 5-or 6-week-old) mice were obtained from the Laboratory Animal Center of Kunming Medical University (Kunming, Yunnan) and housed in a specific pathogen-free facility in a 12-hr light/dark cycle with free access to sterilized food and water. All animals received humane care according to the NIH Guide for Care and Use of Laboratory Animals and the experimental protocol was approved by the Bioethics Committee of Kunming Medical University.
To establish an orthotopic liver xenograft model, individual mice were randomized into two groups using a random number table method (n 5 10 per group) and implanted with Dlg5-stably over-expressing SK-Hep1 or vehicle-transfected control SK-Hep1 cells (2 3 10 6 cells/mouse) in 30 ll Matrigel into their left lobe of the liver, respectively. 26 The mice were monitored daily and on 35 days postimplantation, and the metastatic lung nodules in individual mice were examined by microPET/microCT imaging. Another three nude mice without orthotopically implanted SK-Hep1 cells served as a negative control to confirm the nonspecific uptake of 18F-fluorodeoxyglucose (FDG) sufficiently washed out in the liver and lungs at 60-70 min post-FDG-injection. Subsequently, the mice were sacrificed, and their lungs and livers were excised, fixed in 4% buffed formalin and paraffin-embedded for hematoxylin and eosin staining.
Additional details on materials and methods are described in the Supporting Information.
Results
Dlg5 expression in HCC specimens and cell lines
The Dlg5 expression in 100 pairs of HCC and adjacent nontumor liver tissues was examined by immunohistochemistry. A moderate-strong Dlg5 expression was detected in 70% of nontumor liver tissues (Figs. 1Ab and 1B ), but only in 28% of HCC tissues (P < 0.05, Figs. 1Acdef and 1B), mainly in TNM stage I-II HCC cases (26/28) . Consistently, analysis of mRNA microarray of HCC clinical samples available on Oncomine database indicated lower Dlg5 expression in HCC tissues than in nontumor liver tissues (Supporting Information, Fig. S1A-1C) , and that Dlg5 expression was inversely associated with HCC-BCLC stages in HCC tissues (Supporting Information, Fig. S1D ).
Stratification analysis revealed that the Dlg5 expression was inversely associated with tumor nodules, vascular invasion, cellular differentiation grades, and TNM stages, factors for EMT, stem-like characteristics, invadopodia, and prognosis (Supporting Table 1 ). Indeed, low Dlg5 expression was associated significantly with poor overall survival (median OS of 20 vs 69 months; P 5 0.010, Fig. 1C) , and disease-free survival (median DFS of 16 vs 48 months; P 5 0.017, Fig. 1D ) of HCC patients. Furthermore, while high levels of Dlg5 expression were detected in HL-7702 cells, its expression was associated negatively with invasiveness 10,27-29 of different HCC cell lines (Fig. 1E) . These suggest that Dlg5 may be a suppressor of HCC progression.
Dlg5 inhibits EMT and decreases formation and function of invadopodia in HCC cells
To investigate the potential role of Dlg5 downregulated expression in HCC progression, we tested the impact of Dlg5 silencing by lentiviruses expressing Dlg5-specific shRNAs on the expression of EMT-related molecules, and formation and function of invadopodia in relatively high Dlg5 expressing HepG2 cells. First, infection with lentivirus significantly reduced Dlg5 expression by 90-95% (60% decrease by shRNA3, data not shown, Figs. 2A and 2B) . Second, Dlg5-silencing significantly decreased the levels of E-cadherin, but increased a-SMA and fibronectin expression in HepG2 cells ( Figs. 2A and 2B ). Bright-field images indicated that Dlg5-silencing changed HepG2 cells from a typically cobblestonelike epithelial to fibroblast-like morphology (Fig. 2C) .
Additionally, Dlg5 silencing significantly promoted the formation of invadopodia in HepG2 cells. Evidentially, 20-25% of Dlg5-silenced HepG2 cells exhibited Tks5 and F-actin co-localization, and was significantly higher than 5% of control cells (P < 0.05, Figs. 2D and 2E). Furthermore, the numbers of invadopodia per Dlg5-silenced HepG2 cell were significantly greater than the control (1.5-1.8 vs 0.3, P < 0.05, Fig. 2E) . A similar pattern of Dlg5-silencing effects on colocalization of Cortactin with F-actin was observed in different groups of HepG2 cells (Supporting Information, Figs. S2A and S2B). Moreover, Dlg5-silencing also enhanced the function of invadopodia in HepG2 cells. The numbers of cells degrading gelatin (30-35% vs 7%, P < 0.05) and the relative areas of degraded gelatin per Dlg5-silenced HepG2 cell (5-6 vs 1, P < 0.05) were significantly greater than that in the control (Figs. 2F and 2G) . The Dlg5-silencing effects were reproduced by other Dlg5-specific shRNAs, indicating that the observations were unlikely from an off-target effect of the shRNA. In contrast, induction of Dlg5 overexpression significantly inhibited EMT process, invadopodium formation, and function in naturally Dlg5-deficient SK-Hep1 cells (Supporting Information, Figs. S3A and S3B) . Therefore, the regulation of Dlg5 on invadopodia was not cell-line specific and Dlg5 may inhibit EMT and invadopodium formation and function in HCC cells.
Dlg5 regulates invadopodium-associated invasion of HCC cells, dependent on Tks5
Next, we determined the regulation of Dlg5 on invasion of HCC cells. In comparison with the control, Dlg5 overexpression significantly reduced the numbers of invaded SK-Hep1 cells by 66% (P < 0.05 vs the control; Supporting Information, Fig. S3C ), consistent with previous observations in other types of cancer cells. 18, 19 In contrast, Dlg5 overexpression did not affect the dynamic growth of SK-Hep1 cells (Supporting Information, Fig. S3D ), indicating that inhibition of HCC cell invasion by Dlg5 was not related to cell growth. Further experiments found that knockdown of Tks5 by specific shRNAs did not significantly alter the levels of Dlg5 expression (Fig. 3A) , proliferation, and EMT process, 2 but significantly reduced the invadopodium formation by 50%, gelatin degradation by 50%, and invasion by 30% in the control HepG2 cells (Figs. 3B and 3C) . Notably, Tks5 silencing dramatically inhibited the enhanced invadopodium formation by 90%, gelatin degradation by >90%, and invasion by 40% in the Dlg5-silenced HepG2 cells (Figs. 3B and 3C). The different levels of Tks5 silencing effects between the control and Dlg5-silenced HepG2 cells suggest that other mechanisms, such as Dlg5-modulated EMT process, may regulate the invasion of HepG2 cells (Fig. 3C) . Importantly, induction of shRNA-resistant Tks5 wild-type (WT), but not the Tks5 nonphosphorylatable mutant (Tks5-Y530F/Y592F), expression not only restored Tks5's expression and phosphorylation (Fig. 3A) but also abrogated defective invadopodium formation and function and cell invasion in endogenous Dlg5 and Tks5-silenced HepG2 cells (Figs. 3B and 3C). These indicated that the enhanced invasion induced by Dlg5 silencing was at least partly mediated by increased invadopodium formation and function, which was dependent on Tks5 phosphorylation in HepG2 cells.
Girdin is important for formation and function of invadopodia enhanced by Dlg5-silencing in HCC cells
Girdin is critical for invasion and metastasis of cancer cells. 30 While low levels of Girdin were expressed in HL-7702 cells, the relative levels of Girdin expression were positively associated with invasiveness (Fig. 3D ), but negatively with Dlg5 expression in HCC cells. Infection with lentivirus expressing Girdin-specific shRNAs reduced Girdin expression by 90% (Fig. 3E) , and significantly decreased invadopodium formation and function as well as invasion of control HepG2 cells (Figs. 3F and 3G) . Furthermore, Girdin silencing almost completely demolished the increased invadopodium formation and function and invasion in Dlg5-silenced HepG2 cells (P < 0.05, Figs. 3F and 3G ), which were rescued by ectopic expression of shRNA-resistant Girdin (Figs. 3F and 3G) . Thus, Girdin is important for increased formation and function of invadopodia and invasion of Dlg5-silenced HCC cells.
Dlg5 silencing enhances interplay of Girdin and Tks5
Because both Tks5 and Girdin were crucial for Dlg5-mediated inhibition of invadopodium formation and function and invasion of HCC cells, we further investigated the functional relationships among these three proteins in HCC cells. First, co-immunoprecipitation with anti-Dlg5 detected Girdin and vice versa in HepG2 cells (Figs. 4A and 4B), consistent with previous observations in PC3 and LLc-PK1 cells. 18 However, anti-Dlg5 failed to immunoprecipitate Tks5 (Fig. 4C) . Similarly, anti-Tks5 did not immunoprecipitate Dlg5 in HepG2 cells (data not shown). These indicated that Dlg5 interacted with Girdin, but not directly with Tks5 in HepG2 cells. Given that Girdin has been observed in invadopodia of NIH3T3-Src-Y527F 22 and Girdin can interact with SH3 multiple domains 2 (Wang L, unpublished data), which has similar domain architecture with Tks5 (Supporting Information, Fig. S4 ), we tested whether Girdin could interact with Tks5 in HCC cells. Indeed, anti-Girdin immunoprecipitated a little endogenous Tks5 in the control HepG2 cells but a comparable amount of Girdin co-precipitated much more Tks5, which was mitigated by induction of shRNA-resistant Dlg5 in the Dlg5-silenced HepG2 cells (Dlg5 rescued cells, Fig.  4D ). A similar pattern of immunoprecipitated proteins was detected using anti-Tks5 in different HepG2 cells (Fig. 4E) . Furthermore, immunofluorescence revealed that colocalization of Girdin and Tks5 signals was in the cytoplasm of HepG2 cells, and significantly increased at invadopodiumlike puncta of Dlg5-silenced HepG2 cells, which was significantly reduced in the Dlg5-rescued cells (Pearson's coefficient of 0.5 vs 0.2, P < 0.05; Fig. 4F ). These indicated that Dlg5 bound to Girdin, and interfered with the interaction between Girdin and Tks5, limiting invadopodium formation and function in HCC cells.
Dlg5-silencing enhances Girdin and Tks5 phosphorylation
Tks5 Tyr530 and Tyr592 phosphorylation is necessary for invadopodium formation and function in cancer cells (Fig.  3A) . 8, 9 We investigated whether Dlg5-silencing modulated
Girdin and Tks5 phosphorylation in HepG2 cells. First, low levels of Girdin and Tks5 phosphorylation were detected in the control cells and Dlg5 and/or Girdin silencing did not affect the relative levels of FAK, Src, and Tks5 expression in HepG2 cells (Fig. 5A ). Dlg5-silencing increased the levels of Girdin Ser-1416 and Tyr-1764 phosphorylation, which was abrogated by Girdin silencing and rescued by inducing shRNA-resistant Girdin expression (Fig. 5A) (Fig. 5A) . Furthermore, treatment with PF-573228 or SU-6656, a pharmacological FAK-or Srcspecific inhibitor, significantly reduced Tks5 phosphorylation in the Dlg5-silenced HepG2 cells (Fig. 5B ). These suggest that the enhanced Tks5 phosphorylation by Dlg5 silencing may be mediated by Girdin-dependent FAK/Src activity.
Dlg5 overexpression suppresses metastasis of HCC in vivo
To determine the role of Dlg5 in metastasis of HCC, male BALB/c nude mice were implanted orthotopically with wildtype (control) or Dlg5-stably overexpressing (Dlg5) SK-Hep1 cells (n 5 10 per group), respectively. The lung metastatic tumors were monitored at 35 days postimplantation by microPET/microCT imaging. Clearly, the radioactive signals in the lungs of the control mice were significantly higher than that in the Dlg5 group of mice (Figs. 6A and 6B ). Histological examination revealed that the numbers and sizes of intrahepatic and lung metastatic tumor nodules in the control mice were significantly greater than that in the Dlg5 group of mice (Figs. 6C-6F and Supporting Information, Fig. S5) . Notably, control SK-Hep1 cells invaded into the surrounding liver stroma and formed microsatellites, while Dlg5-overexpressing SK-Hep1 tumors had a complete boundary in the liver (Fig. 6E) . Together, these demonstrated that Dlg5-overexpression inhibited local invasion and the lung metastasis of HCC in vivo.
Discussion
In this study, we identified a unique function of Dlg5 in inhibiting invadopodium formation and gelatin degradation and provided new insights into the molecular mechanisms of HCC cell invasion. Our results, together with previous publications, 7, 8 support a working model (Supporting Information, Fig. S6A ) that (1) Dlg5 binds to Girdin and inhibits its activation and binding to Tks5; (2) some HCC progression factors reduce Dlg5, which leaves free Girdin activation and binding to Tks5; (3) the interaction between Girdin and Tks5 promotes Tks5 tyrosine phosphorylation, which is mediated by Girdin-dependent FAK/Src activity; (4) consequently, activated Tks5 triggers invadopodium development through two established cascades: First, Tks5 phosphorylation recruits Nck1/2 and potentially Grb2, which can bind and activate N-WASP-Arp2/3 actin nucleation complex via their SH3 domain to facilitate actin network assembly, leading to the essential skeleton of invadopodia. 7 Furthermore, the phosphorylation of two tyrosine residues in Tks5 between its third and fourth SH3 domains causes its conformational changes, which expose Tks5 SH3 domains for direct binding of N-WASP. 7, 9 Notably, a recent study suggests that the enhanced FAK (and Src) activation by Girdin may be mediated by PI3K activation. 23 Indeed, Girdin on the cellular membrane can activate heterotrimeric G protein signaling, 21 which in turn activates the PI3K signaling, 32 and the PI3K and its major effector Akt have been demonstrated to be instrumental in invadopodium formation and function. 33 These findings provide a valuable example, in which a single molecule (Dlg5) coordinates EMT and invadopodia to promote cell invasion. In this study, Dlg5-silencing dramatically provoked EMT in HepG2 cells, consistent with that in renal proximal tubular epithelial LLc-PK1 and prostate cancer PC3 cells. 14, 18 These changes elicited by Dlg5 knockdown may allow individual tumor cells to dissociate from each other, and provide a prerequisite for further escape from the primary lesion. Furthermore, Dlg5 silencing promoted invadopodium formation and function, which correlated with increased association between Girdin and Tks5. Because knockdown of Tks5 mitigated the increase in invadopodia but did not completely demolish the invasion of Dlg5-silenced HCC cells (Fig. 3C) , we reasoned that both the enhanced EMT and invadopodia induced by Dlg5-silencing are required for maximizing cell invasion in HCC cells.
A previous study has reported that Twist1 can trigger EMT program by inhibiting E-cadherin transcription, and inducing PDGFRa expression simultaneously, leading to autocrine phosphorylation of PDGFRs. Subsequently, the activated PDGFRs activate Src and its downstream Cortactin and Tks5 to promote invadopodium development in breast cancer. 2 Taken together, these findings extend our established knowledge and suggest that the coordination of EMT and invadopodia may broadly exist in different types of invasive cancers to obtain optimal invasion ability of cancer cells although the different mechanisms may be involved.
Clinically, this study provided novel insights into the possible use of Dlg5 as an HCC biomarker and at least partly pinpointed the potential role of Dlg5 in HCC progression (Supporting Information, Fig. S6B ): High levels of Dlg5 expression were expressed in nontumor liver tissues, but reduced with HCC progression. Furthermore, the Girdin expression was positively associated with HCC progression. 34 The imbalance between Dlg5 and Girdin expression may gradually increase Girdin and Tks5 activity during the HCC progression. Consequently, during the early stage of HCC progression, HCC cells may preferentially have more and stronger cell-cell junctions, but fewer invadopodia, to favor HCC growth. However, in the later stage, HCC cells may favor more invadopodia, but fewer or weaker cell-cell junctions, to promote HCC invasion. This model may at least partly explain why low Dlg5 expression was associated with a poor prognosis of HCC patients, aggressiveness of HCC and cell lines, and Dlg5 overexpression inhibited the lung metastasis in mice. Moreover, given low levels of Dlg5 expression in the breast, prostate, and bladder cancer, [17] [18] [19] we reasoned that this model may be extrapolated to these situations.
Notably, Dlg5 silencing did not affect the levels of Girdin expression in HepG2 cells (Fig. 3E) , although Dlg5 expression was inversely associated with Girdin in HCC tissues (our results combined with a previous report 34 ) and cell lines. These suggest that independent mechanisms related to HCC progression may regulate Dlg5 and Girdin expression, respectively. Full-length Girdin expression is downregulated by an alternatively splicing event in the early stage of tumor progression, 35 and can be upregulated by STAT3 activation in the late stage of tumor progression. 36, 37 Dlg5 expression can be downregulated by TGF-b1, 14 which is elevated in HCC patients, particularly with aggressive and metastatic HCC. 38 Indeed, our findings have shown that TGF-b1 treatment downregulates Dlg5 expression in HCC cell lines (Wang L, unpublished data). Dlg5 can interact with TGF-b receptors and promote their proteasome-dependent degradation. It is possible that the downregulated Dlg5 expression by TGF-b1 stimulation may reflect a positive feedback amplification of the TGF-b1 signaling. 15 Moreover, the downregulated Dlg5 expression is associated with high methylation of CpG islands in aggressive bladder cancer cells 19 and with a microRNA overexpression in aggressive HCC cells (Wang L, unpublished data). We are interested in further investigating molecular mechanisms, by which Dlg5 and Girdin were deregulated in HCC cells.
The effect of Dlg5 on cancer growth appeared to be variable. First, Dlg5 overexpression did not significantly affect proliferation of cultured SK-Hep1 cells (Supporting Information, Fig. S3D ). However, it significantly reduced the size of metastases in the lungs and livers of mice (Supporting Information, Fig. S5 ). Interestingly, two previous studies have shown that Girdin and Tks5 are responsible for cancer cell growth in 3 D matrices and in vivo, but not cell proliferation in vitro. 22, 39 Given that the Dlg5 overexpression suppressed invadopodia and that Girdin and Tks5 are also required for invadopodium formation, these results suggest that invadopodia may be integral for cancer cell growth in response to ECM microenvironment. Indeed, invadopodia orchestrate the processing VEGF and other growth factors to mature and active forms by extracellular proteases. 39 Further studies are needed to demonstrate the possibility.
In conclusion, our data indicate that Dlg5 acts as a novel regulator of invadopodia through a mechanism that requires Girdin and Tks5. Our data are consistent with a role of Dlg5 in attenuating the interaction between Girdin and Tks5 and inhibiting Tks5 activation in HCC cells. In view of the established relationship between Dlg5 and EMT, these findings may create a new paradigm, in which a single signal transducer centrally integrates and broadly shapes the process of EMT and invadopodia to enhance invasion coordinately. Furthermore, given that Dlg5 expression is closely related to clinical outcomes of HCC patients, Dlg5 may be a novel biomarker for prognosis of HCC patients to improve personalized medicine.
